Individual Treatments (Comprehensive Genomic Profiling)

What Is Personalized Treatment?

Personalized treatment—also known as precision medicine—is a modern medical approach that tailors diagnostic and therapeutic strategies to the individual characteristics of each patient. Rather than applying a uniform treatment for all patients with the same condition, personalized medicine considers a wide range of individual factors, including genetic makeup, molecular biomarkers, lifestyle habits, environment, and the biological behavior of the disease itself. This shift from a “one-size-fits-all” approach to individualized care aims to increase treatment effectiveness while reducing avoidable side effects and unnecessary interventions.

In traditional medicine, treatment decisions often rely on population-based studies that show what works for the majority of patients. However, every patient’s disease can behave differently—especially in conditions like cancer, where tumor biology varies widely from one person to another. Personalized treatment addresses this variability by identifying the specific alterations or molecular pathways driving a patient’s disease. These insights enable clinicians to select the therapies most likely to work for that individual.

This approach is especially important in several fields:

Cancer Therapy

Modern oncology has been transformed by personalized medicine. Many advanced or treatment-resistant tumors harbor genetic mutations that directly influence how they respond to therapy. By identifying these mutations, clinicians can prescribe targeted therapies, immunotherapies, or combination treatments tailored to the tumor’s unique biology. This significantly increases treatment precision and minimizes side effects associated with ineffective treatments.

Rare Genetic Disorders

Rare diseases often have a strong genetic basis. Personalized treatment allows physicians to pinpoint the specific gene mutation responsible for the disorder and select targeted interventions, enzyme therapies, or gene-based treatments when available.

Chronic Illnesses

For chronic cardiovascular, immunological, or metabolic conditions, personalized medicine can help predict treatment response, lower the risk of adverse events, and guide long-term disease management strategies.

By focusing on each patient’s unique clinical and biological profile, personalized treatment provides a higher quality of care, enhances treatment outcomes, and improves overall quality of life.

How Is Comprehensive Genomic Profiling Performed?

Comprehensive genomic profiling (CGP) is the scientific backbone of personalized treatment. It involves an in-depth analysis of tumor DNA, RNA, or sometimes blood-based biomarkers to identify genetic mutations, expression patterns, molecular pathways, and potential therapeutic targets. This advanced testing helps physicians determine the most effective treatment strategy for each patient.

Below are the major steps involved:

1. Sample Collection

The process begins with obtaining a biological sample. Depending on the condition, this may include:

• Tumor tissue biopsy (solid tumors)

   

• Bone marrow samples (blood cancers)

   

• Blood samples, known as liquid biopsy (useful when tumor tissue is inaccessible)

   

Liquid biopsy is increasingly important in modern oncology because it is less invasive and can be repeated to monitor changes during treatment.

2. Next-Generation Sequencing (NGS)

Next-Generation Sequencing is a high-throughput method that analyzes thousands of genes simultaneously. During this step:

• DNA and RNA are sequenced to detect mutations, rearrangements, gene amplifications, or deletions.

   

• Transcriptomic and proteomic patterns may also be studied in advanced profiling.

   

• The sequencing results provide a detailed map of genetic abnormalities that may influence disease behavior or drug response.

   

NGS is far more comprehensive than traditional genetic tests, which may analyze only one or a few genes at a time.

3. Data Interpretation

After sequencing, a team of expert molecular pathologists, geneticists, and clinicians reviews the results. They identify:

• Actionable mutations (mutations that can be targeted by existing therapies)

   

• Prognostic markers (mutations that indicate disease aggressiveness)

   

• Diagnostic markers (alterations that help confirm specific disease subtypes)

   

• Potential clinical trial opportunities

   

This multidisciplinary interpretation ensures that all relevant therapeutic possibilities are considered.

4. Therapy Planning

Once actionable findings are identified, clinicians develop a personalized treatment strategy. This can include:

• Targeted therapies (e.g., EGFR inhibitors, ALK inhibitors, BRAF inhibitors)

   

• Immunotherapy based on biomarkers like PD-L1 expression or tumor mutational burden

   

• Hormone therapies, when applicable

   

• Combination therapies tailored to mutation patterns

   

• Enrollment in clinical trials offering innovative treatment options

   

By using genomic data to guide therapy decisions, clinicians can avoid ineffective treatments and increase the likelihood of a positive clinical response.

Who Can Benefit from Personalized Treatments?

Although personalized medicine is widely known for its role in cancer treatment, its benefits extend across multiple areas of medicine. The patients who benefit most include:

1. Patients with Advanced or Resistant Cancers

For tumors that do not respond to standard therapy, genomic profiling can reveal hidden mutations that may be treatable with targeted drugs or immunotherapies.

2. Individuals with Rare Genetic or Metabolic Disorders

Many rare diseases are linked to specific genetic abnormalities. Personalized treatment helps:

• Identify the underlying mutation

   

• Guide management strategies

   

• Predict disease progression

   

• Recommend emerging molecular therapies

   

3. Patients with Chronic Conditions

Certain long-term diseases—such as cardiovascular disorders, autoimmune diseases, and chronic inflammatory conditions—may require individualized medication planning to optimize effectiveness and reduce side effects.

4. Patients Seeking Better Prediction and Prevention

Some individuals choose personalized approaches to understand their genetic predisposition to certain diseases. This helps inform early preventive strategies, lifestyle adjustments, and long-term health planning.

By identifying how each patient’s body and disease function at the molecular level, personalized treatment enhances outcomes, supports safer clinical decision-making, and offers a more patient-centered healthcare experience.

Advantages of Personalized Treatment

Personalized medicine provides several important advantages over conventional treatment approaches:

Higher Treatment Effectiveness

Therapies are selected based on the specific molecular drivers of disease, leading to better treatment responses and higher success rates.

Reduced Side Effects

By eliminating unnecessary medications and choosing targeted therapies, the risk of adverse reactions is significantly lowered.

Efficient Use of Healthcare Resources

Precision-based therapy allows clinicians to focus on treatments that are most likely to work, saving time, cost, and resources.

Shorter Time to Effective Treatment

Instead of trial-and-error treatment, personalized medicine identifies effective options from the outset, reducing delays in achieving therapeutic benefit.

Improved Quality of Life

Patients generally experience fewer complications and better long-term outcomes when treatment is tailored to their biology.

These advantages make personalized medicine a powerful tool for improving patient outcomes while elevating the standard of care in modern healthcare systems.

Conclusion

Personalized treatment and comprehensive genomic profiling represent a major evolution in modern medicine. By decoding diseases at the genetic and molecular levels, clinicians can move beyond generic treatment protocols and instead offer therapies tailored to each patient’s unique needs. This approach is especially transformative in fields like oncology, where genomic insights directly influence treatment choices, response rates, and patient survival.

At Medical Point Hospital, personalized medicine is fully integrated into oncology, genetics, and specialty care programs. Our medical teams utilize advanced genomic technologies, multidisciplinary expertise, and the latest targeted therapies to develop individualized treatment plans for patients with complex, treatment-resistant, or rare conditions.

As genomic science continues to advance, personalized treatment will become even more accessible—offering new hope, better outcomes, and more precise care for patients across a wide range of medical needs.